Novel coronavirus pneumonia (COVID-19)
Conditions
Interventions
Experimental group:On the basis of routine treatment, add 100ml of normal saline and 50ml of Xuebijing injection twice a day
Control group:conventional therapy
Sponsors
Jingzhou First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. The patient signs the written informed consent; 2. Aged 18-80 years; 3. the novel coronavirus novel coronavirus infection diagnostic criteria for pneumonia, namely, the new coronavirus pneumonia diagnosis and treatment plan (trial version sixth). It conforms to any of the following: 1) in case of shortness of breath, RR >= 30 times / min; 2) in case of resting state, oxygen saturation 50% should be treated as severe management; 4. The course of disease is within 14 days after onset.
Exclusion criteria
Exclusion criteria: 1. Those who are allergic to Xuebijing injection and its components; 2. Pregnant or lactating women; 3. Serious basic diseases affecting survival, including: malignant tumor, hematopathy, HIV, etc; 4. Expected death within 48 hours; 5. Patients who are participating in other clinical trials; 6. The researchers think other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of patients who convert to moderate one;The rate of shock;Endotracheal intubation ratio;Time spent on the ventilator;mortality;Time of virus nucleic acid test turning negative; | — |
Secondary
| Measure | Time frame |
|---|---|
| CRP;IL-6;TNF-a;Time of improvement of clinical symptoms (fever, cough);Adverse drug reactions;white blood cell;lymphocyte;IL-8;length of stay in ICU;average length of hospitalization; | — |
Countries
China
Contacts
Public Contactxiao wei
Jingzhou First People's Hospital
Outcome results
None listed